20LBA What is the current evidence for adding docetaxel or bisphosphonates to androgen deprivation therapy (ADT) in men with hormone sensitive prostate cancer? A systematic review and meta-analyses. (September 2015) - Vale, C.; Rydzewska, L.H.; Tierney, J.F.; Albiges, L.; Clarke, N.W.; Fisher, D.J.; Fizazi, K.; James, N.D.; Mason, M.D.; Parmar, M.K.; Sweeney, C.J.; Sydes, M.R.; et al.